Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2022 Jan 14;16(1):e0010136. doi: 10.1371/journal.pntd.0010136

Meta-analysis of variable-temperature PCR technique performance for diagnosising Schistosoma japonicum infections in humans in endemic areas

Meng-Tao Sun 1, Man-Man Gu 1, Jie-Ying Zhang 1, Qiu-Fu Yu 1, Poppy H L Lamberton 2, Da-Bing Lu 1,*
Editor: John Stuart Gilleard3
PMCID: PMC8794272  PMID: 35030167

Abstract

Background

As China is moving onto schistosomiasis elimination/eradication, diagnostic methods with both high sensitivity and specificity for Schistosoma japonicum infections in humans are urgently needed. Microscopic identification of eggs in stool is proven to have poor sensitivity in low endemic regions, and antibody tests are unable to distinguish between current and previous infections. Polymerase chain reaction (PCR) technologies for the detection of parasite DNA have been theoretically assumed to show high diagnostic sensitivity and specificity. However, the reported performance of PCR for detecting S. japonicum infection varied greatly among studies. Therefore, we performed a meta-analysis to evaluate the overall diagnostic performance of variable-temperature PCR technologies, based on stool or blood, for detecting S. japonicum infections in humans from endemic areas.

Methods

We searched literatures in eight electronic databases, published up to 20 January 2021. The heterogeneity and publication bias of included studies were assessed statistically. The risk of bias and applicability of each eligible study were assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 tool (QUADAS-2). The bivariate mixed-effects model was applied to obtain the summary estimates of diagnostic performance. The hierarchical summary receiver operating characteristic (HSROC) curve was applied to visually display the results. Subgroup analyses and multivariate regression were performed to explore the source of heterogeneity. This research was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was registered prospectively in PROSPERO (CRD42021233165).

Results

A total of 2791 papers were retrieved. After assessing for duplications and eligilibity a total of thirteen publications were retained for inclusion. These included eligible data from 4268 participants across sixteen studies. High heterogeneity existed among studies, but no publication bias was found. The pooled analyses of PCR data from all included studies resulted in a sensitivity of 0.91 (95% CI: 0.83 to 0.96), specificity of 0.85 (95% CI: 0.65 to 0.94), positive likelihood ratio of 5.90 (95% CI: 2.40 to 14.60), negative likelihood ratio of 0.10 (95% CI: 0.05 to 0.20) and a diagnostics odds ratio of 58 (95% CI: 19 to 179). Case-control studies showed significantly better performances for PCR diagnostics than cross-sectional studies. This was further evidenced by multivariate analyses. The four types of PCR approaches identified (conventional PCR, qPCR, Droplet digital PCR and nested PCR) differed significantly, with nested PCRs showing the best performance.

Conclusions

Variable-temperature PCR has a satisfactory performance for diagnosing S. japonicum infections in humans in endemic areas. More high quality studies on S. japonicum diagnostic techniques, especially in low endemic areas and for the detection of dual-sex and single-sex infections are required. These will likely need to optimise a nested PCR alongside a highly sensitive gene target. They will contribute to successfully monitoring endemic areas as they move towards the WHO 2030 targets, as well as ultimately helping areas to achieve these goals.

Author summary

Schistosoma japonicum is a parasite that can cause serious intestinal schistosomiasis. The infection is mainly diagnosed by parasitological and immunological methods, such as Kato-Katz test and indirect hemagglutination assay. However, both of these are not sensitive enough to accurately assess schistosomiasis elimination/eradication. PCR assays, detecting parasite DNA, are theoretically a highly suitable, sensitive and specific, alternative. However, reported performance varies greatly among studies. Therefore, we performed this meta-analysis (PROSPERO, registered No. CRD42021233165) to analyze and summarize the data from relevant studies of variable-temperature PCR for the diagnosis of S. japonicum infections, using stool or blood samples from humans in endemic areas. We retrieved a total of 13 eligible articles including data from 4268 participants across 16 studies. There was high heterogeneity among studies, but no publication bias was found. Analyses revealed that PCR techniques had a satisfactory performance for diagnosing S. japonicum infections in humans in endemic areas, with both high sensitivity and specificity. Further research on S. japonicum diagnostic techniques, especially in low endemicity areas and for detection of dual-sex and single-sex infections are required. These may be best using highly sensitive gene targets in nested PCR reactions.

Introduction

Schistosomiasis is the second most important human parasitic disease in the world with approximately 240 million people infected and more than 700 million people living at risk of infection [1]. The loss in disability-adjusted life years caused by this disease ranked third among a series of over 20 neglected tropical diseases [2,3]. The majority of human schistosomiasis is caused by three main schistosome species: Schistosoma mansoni, Schistosoma haematobium and Schistosoma japonicum. Schistosomiasis occurrs mainly in Africa and Asia, with a low prevalence in South America and the Middle East [4,5].

China and the Republic of the Philippines are the only two counties now endemic with S. japonicum, which is regarded to cause the most serious pathology and disease due to its highest egg output [6]. S. japonicum remains a major public health problem and in China has been set as one of the four top priorities for communicable disease control by the central government [79]. After implementing effective prevention and control measures for nearly 70 years, great progress has been achieved with a significant reduction in S. japonicum prevalence, intensity and associated morbidity in many endemic areas [10]. In 2014, China proposed a two-stage road map for schistosomiasis control and elimination: to achieve transmission interruption by 2020 and then to eliminate the disease at the country level by 2030 [11,12]. The government is making a considerable effort to keep the transmission of schistosomiasis interrupted region by region [1316]. Whilst moving towards these goals of elimination, and beyond during post intervention surveillance, diagnostics that are highly sensitive and specific will be required [1719]. These diagnostics could be critical as elimination/eradication assessment requires confirmation that no new infection cases have occurred. Any inaccurate diagnoses would make a wrong estimation of the disease prevalence and, depending on criteria cut offs, may then affect the final elimination status. However, currently there is no standardized highly sensitive and specific diagnostic technology available for S. japonicum infections.

At present, there are three main groups of diagnostic approaches for schistosome infections in humans: parasitological, immunological, and DNA-based methods. Parasitological assays, such as Kato-Katz detecting schistosome eggs in stool under a microscope, are recommended by the World Health Organization (WHO) for S. japonicum [20]. However, Kato-Katz have been proven to have a low sensitivity in people with low infection intensities and in areas with low prevalence [21]. Immunological tests can be divided into two categories: antigen tests and antibody tests. Whilst there is a highly specific antigen test available for use in the field for S. mansoni, there are no point of care antigen tests available for S. japonicum. Antibody tests are now commonly used for S. japonicum [22,23], but they are unable to distinguish current from previous infections [19,24,25], which make it impossible to assess active transmission and monitor for eradication/elimination. PCR-based molecular methods, to detect parasite DNA, have recently been developed and applied to the diagnosis of a broad number of infections including Schistosoma spp, and have primarily shown high diagnostic values [2628]. Generally, there are four main kinds of PCR methods used to diagnose Schistosoma infections, namely conventional PCR, nested PCR, real-time PCR, and droplet digital PCR. Conventional PCR uses a pair of primers to amplify the target sequence millions of times. For nested PCR, a pair of primers is used to amplify the target sequence to increase the amount of template and then a pair of inner primers is used to amplify the target gene fragment [29]. Conventional and nested PCRs give a positive or negative response, but are not quantitative. Real-time PCR can quantify the copies of the target sequence in samples and is often called qPCR [30]. Droplet digital PCR is developed on the basis of water-oil emulsion droplet technology, which casuses the sample to fractionate into 1000s of droplets and the PCR reactions occur within each droplet, with the proportion of droplets that have PCR amplicon in also resulting in a quantitative measure [31,32].

As a range of protocols, and/or different biological samples, have been used for PCR diagnoses of schistosome infections, the reported diagnostic performances or estimates of such techniques have therefore also varied greatly [33]. Whilst many studies find PCR to be highly specific and sensitive, PCR diagnostic accuracies have been reported to be considerably lower than the commonly used indirect hemagglutination assay [34]. Therefore, we performed a meta-analysis of data from studies using PCRs on DNA extracted from human serum or stools, to evaluate the overall diagnostic value of variable-temperature PCR technology for S. japonicum infections in terms of comprehensive indexes, when compared to the conventional Kato-Katz method.

Methods

Study registration

This research was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines (S1 Table) [35] and was registered prospectively in PROSPERO (CRD42021233165) [36].

Searching strategy and selection criteria

This meta-analysis assessed diagnostic accuracy of the current assays based on variable-temperature PCR for the detection of S. japonicum in humans. We searched relevant literatures up to 20 January 2021 from electronic databases, including China National Knowledge Infrastructure (CNKI), WanFang Database, Chinese Scientific Journal Databases (VIP), PubMed, Elsevier Science Direct, ProQuest, Whiley Online Library and Web of Science. The words of “ribenxuexichong”, “PCR” and “jiance” (pinyin in Chinese) were used as keywords to search Chinese databases. “Schistosoma”, “PCR” and “detection” were used to search English databases. In order to expand the scope of the search, relevant references of the included literatures were also searched.

Literature selection criteria were that the paper included: (1) humans as subjects; (2) blood/serum or stool as the biological samples; (3) sample sizes over 10; (4) PCR techniques limited to variable-temperature nucleic acid amplification; (5) parasitological tests (i.e. Kato-Katz or hatching test) as the reference standard; (6) both sensitivity and specificity reported, or data available so that they could be calculated. Literatures that did not meet any of the above criteria were excluded.

Data extraction process and quality assessment

Two reviewers (MS and MG) screened the papers and performed data extraction separately, and any disagreements were resolved through discussion with the third reviewer (JZ). The following information was extracted from each eligible publication: first author; year of publication; type of evaluation; design type (case-control or cross-sectional design); reference standard; sample size; biological sample (stool or blood/serum); index test (conventional, nested, real-time or droplet digital PCR); human population; setting (endemic/non-endemic area); and the gene which the PCR targeted. Papers evaluating more than one molecular method or using more than one target gene were considered as different studies. The two reviewers independently assessed the risk of bias and applicability of each eligible study using the Quality Assessment of Diagnostic Accuracy Studies 2 tool (QUADAS-2) [37]. When there were inconsistent evaluation opinions, they would discuss with the third reviewer and made a final decision.

Statistical analysis

Statistical analyses were performed using Review Manager 5.4 [38], Stata 15.0 [39] and R 4.0.4 [40] software. Risk of bias and applicability concern summaries and graphs for all included studies were automatically analyzed in Review Manager 5.4. The heterogeneity was assessed by Q test and I-square test statistically. If the I-square statistic was more than 50%, and P was less than 0.1, then it would be considered that there was substantial heterogeneity among the studies [41]. Spearman correlation coefficients of logit (true positive rate) and logit (false positive rate) were calculated to assess if there was a threshold effect [42]. The Deek’s funnel plots were used to assess the publication bias and a P value of >0.1 represented no publication bias [43]. The bivariate boxplot was employed to assess the distribution properties of sensitivity versus specificity and for identifying possible outliers [44].

The bivariate mixed-effects model [45], taking heterogeneity and threshold effect into account, was applied to obtain the summary estimates of sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic odds ratio (DOR) by using MIDAS in STATA 15.0. A reliable diagnostic assay is suggested to have a PLR greater than 10 and a NLR less than 0.1 [46,47]. Hierarchical summary receiver operating characteristic (HSROC) curves [48] were created and applied to visually display the pooled sensitivity, specificity and their 95% confidence intervals (CIs). 95% prediction regions within each study, were denoted as a dot in the forest plots and HSROCs. The correlation between sensitivity and specificity among studies was analyzed to justify the bivariate model used. Subgroup analyses and multivariate meta-regression were performed within R to explore the source of heterogeneity and investigate the main factors influencing diagnostic accuracy.

Results

Literature search

Fig 1 summarizes the study selection process. We retrieved articles in eight databases: CNKI (813 related records), WanFang (707), VIP (324), PubMed (185), Elsevier Science Direct (271), ProQuest (211), Wiley Online Library (51) and Web of Science (229). Eight further records were identified through reference lists. A total of 1791 records were retained for comparison after duplicates had been removed. Of these, 1591 records were excluded due to the absence of S. japonicum. After reading the full texts, 187 records were deleted: one due to duplicate data, one due to having no specificity data, one with a sample size of less than ten, five with no variable-temperature PCR used and 179 with no human blood or stool samples used.

Fig 1. Flow chart of studies on S. japonicum infections detected by PCR tests.

Fig 1

The chart shows numbers of titles and studies reviewed in preparation of this meta-analysis. N, the number of studies included in each stage of the process.

Eventually, 13 articles [33,4960] with a total of 4268 participants were included in this meta-analysis. Three articles reported two studies regarding PCR. Xu J et al. 2011 [58] examined the diagnostic accuracy of both conventional PCR and nested PCR. Kosala G. Weerakoon et al. 2017 [33] used both blood and stool samples for their droplet digital PCR, and Yi Mu et al. 2020 [55] used two molecular markers (sja-miR-2b-5p and sja-miR-2c-5p) in their real-time PCR. Therefore, a total of 16 studies, with eleven based on serum and five on stool samples, were included. 14 studies were conducted in S. japonicum endemic areas of China and 4 studies were conducted in S. japonicum endemic areas of the Republic of the Philippines. Out of the 16 studies, six evaluated conventional PCR, three nested PCR, five real-time PCR, and two droplet digital PCR. Key details of the included studies are shown in Tables 1 and 2. Quality assessment is demonstrated in Supplement file (S1 Fig). The high-risk items were mainly Patient Selection and Index Test, in particular, seven articles were based on a case-control design and some of them did not give a clear description of whether the participants were included at random. Applicability Concerns were assessed as low risk because all the publications showed that the information which they provided met the QUADAS-2 standard.

Table 1. Characteristics of the eligible publications included in the analysis.

Study Sample size Design Biological sample Index test Population Setting Target gene
Fung 2012 [49] 106 Cross-sectional Stool Conventional PCR All ages Endemic area in Sichuan, China SjR2
Gordon 2015 [50] 560 Cross-sectional Stool Real-time PCR All ages Endemic area in Laoang and Palapag municipalities, Northern Samar, the Philippines NADH 1
Guan 2013 [51] 71 Case-control Serum Real-time PCR - Endemic area in Hunan, China SjR2
Guo 2012 [52] 94 Case-control Serum Nested PCR - Endemic areas in Hunan and Suzhou, Jiangsu, China SjCHGCS19
Kato-Hayashia 2015 [53] 23 Cross-sectional Serum Conventional PCR All ages Endemic area in Sorsogon, the Philippines COI
Lier 2009 [54] 1106 Cross-sectional Stool Real-time PCR - Endemic area in the Yangtze River in Tongling, Anhui, China NADH 1
Mu 2020a/b [55] 78 Cross-sectional Serum Real-time PCR All ages Endemic area in Laoang and Palapag, Northern Samar, the Philippines Sja-miR-2b-5p/ Sja-miR-2c-5p
Wang 2009 [56] 75 Case-control Stool Conventional PCR - Endemic area in Anqing, Anhui and non-endemic area in Hanshan, Anhui China 14-3-3 protein mRNA
Weerakoon 2017a/b [33] 412 Cross-sectional Serum /Stool Droplet digital PCR All ages Endemic area in Laoang and Palapag municipalities, Northern Samar, the Philippines NADH 1
Xu 2010 [57] 50 Case-control Serum Conventional PCR - Endemic area in Hunan and Suzhou, Jiangsu, China SjR2
Xu 2011a/b [58] 215 Case-control Serum Conventional PCR/Nested PCR - Endemic areas in Hunan and Wuxi, Jiangsu, China SjR2
Xu 2014 [59] 1371 Cross-sectional Serum Conventional PCR All ages Endemic area of southeastern Poyang Lake, Jiangxi, China SjR2
Zeng 2017 [60] 107 Case-control Serum Nested PCR All ages Endemic area in Hunan, China SjR2

Note

a/b, two studies within the publication.

Table 2. Raw data from included studies.

Author Tp Fp Fn Tn N
Fung 2012 [49] 14 2 8 82 106
Gordon 2015 [50] 121 384 7 48 560
Guan 2013 [51] 39 0 2 30 71
Guo 2012 [52] 42 2 1 49 94
Kato-Hayashi 2015 [53] 1 9 0 13 23
Lier 2009 [54] 32 35 39 1000 1106
Mu 2020_a [55] 36 8 17 17 78
Mu 2020_b [55] 42 11 11 14 78
Wang 2009 [56] 31 0 0 44 75
Weerakoon 2017_a [33] 102 176 6 128 412
Weerakoon 2017_b [33] 106 201 2 103 412
Xu 2010 [57] 18 0 12 20 50
Xu 2011_a [58] 96 7 14 98 215
Xu 2011_b [58] 98 9 12 96 215
Xu 2014 [59] 71 394 3 903 1371
Zeng 2017 [60] 74 21 0 12 107

Tp = number of true positive samples; Fp = number of false positive samples; Fn = number of false negative samples; Tn = number of true negative samples; N = total number of samples tested.

Heterogeneity analysis

There was no threshold effect, as indicated by the spearman coefficient (rs = 0.311, P = 0.242). When comparing paired sensitivity and specificity of all studies (Fig 2), point values were not in a straight line. The I-squared values of sensitivity and specificity were respectively 97.30 and 99.14 (both P<0.05), suggesting an existence of substantial heterogeneity among studies. The bivariate boxplot (Fig 3) shows that no studies fell outside the 95% CIs. Deek’s funnel plot (Fig 4) shows that studies were roughly equally distributed on each side of the regression line with no obvious publication bias (b = 24.09, P = 0.13).

Fig 2. Paired forests of pooled sensitivity and specificity of all included studies.

Fig 2

Fig 3. Bivariate boxplots of all included studies.

Fig 3

Fig 4. Assessment of publication bias by Deek’s funnel plot asymmetry test.

Fig 4

Pooling diagnostic accuracy

Across all studies and tests there was a negative correlation between sensitivity and specificity (r = -0.36, P = 0.17). The bivariable mixed-effects model was used to perform the analyses for the overall diagnostic accuracy and subgroup estimates. As seen in Table 3, the pooled accuracy of all 16 studies resulted in a sensitivity of 0.91 (95% CI: 0.83 to 0.96), specificity of 0.85 (95% CI: 0.65 to 0.94), PLR of 5.90 (95% CI: 2.40 to 14.60), NLR of 0.10 (95% CI: 0.05 to 0.20) and DOR of 58 (95% CI: 19 to 179). A global summary of the diagnostic performance of PCRs across all of the 16 studies is presented in Fig 5.

Table 3. Subgroup analysis of diagnostic accuracy.

Sensitivity Het. Specificity Het. PLR Het. NLR Het. DOR Het.
(95% CI) (I2%, P) (95% CI) (I2%, P) (95% CI) (I2%, P) (95% CI) (I2%, P) (95% CI) (I2/%, P)
Overall 0.91
(0.83, 0.96)
97.3; <0.01 0.85
(0.65, 0.94)
99.1; <0.01 5.90
(2.40, 14.60)
99.4; <0.01 0.10
(0.05, 0.20)
97.4; <0.01 58
(19, 179)
100; <0.01
Research design
Cross-sectional 0.87
(0.73, 0.94)
97.4; <0.01 0.67
(0.39, 0.86)
99.4; <0.01 2.60
(1.30, 5.00)
99.0; <0.01 0.20
(0.11, 0.34)
96.7; <0.01 13
(6, 28)
100; <0.01
Case-control 0.95
(0.82, 0.99)
92.6; <0.01 0.96
(0.80, 0.99)
96.1; <0.01 26.0
(4.30, 158.60)
96.6; <0.01 0.05
(0.01, 0.20)
92.9; <0.01 512
(77, 3405)
88.0; <0.01
Biological materials
Stool 0.91
(0.63, 0.98)
99.6; <0.01 0.87
(0.32, 0.99)
99.8; <0.01 7.20
(0.70, 72.30)
99.9; <0.01 0.10
(0.02, 0.51)
99.6; <0.01 69
(4, 1218)
100; <0.01
Serum 0.92
(0.83, 0.96)
89.9; <0.01 0.83
(0.63, 0.93)
96.2; <0.01 5.30
(2.30, 12.30)
95.1; <0.01 0.10
(0.05, 0.21)
88.2; <0.01 53
(17, 165)
100; <0.01
PCR type
Conventional PCR 0.86
(0.82, 0.90)
86.5; <0.01 0.74
(0.72, 0.76)
95.7; <0.01 11.37
(1.47, 88.06)
97.1; <0.01 0.18
(0.07, 0.44)
87.0; <0.01 73.76
(28.95, 187.95)
38.2; 0.15
Nested PCR 0.94
(0.90, 0.97)
86.0; <0.01 0.83
(0.77, 0.88)
96.0; <0.01 7.06
(0.72, 68.88)
97.5; <0.01 0.05
(0.01, 0.23)
55.8; 0.10 158.62 (36.17, 695.63) 43.1; 0.17
Real-time PCR 0.78
(0.73, 0.82)
94.7; <0.01 0.72
(0.69, 0.74)
99.7; <0.01 4.121
(0.74, 21.69)
98.8; <0.01 0.39
(0.24, 0.62)
74.2; <0.01 10.06
(2.72, 37.26)
88.6; <0.01
Droplet digital PCR 0.96
(0.93, 0.98)
53.9; 0.14 0.38
(0.34, 0.40)
77.1; 0.04 1.55
(1.41, 1.70)
47.9; 0.17 0.10
(0.05, 0.23)
19.3; 0.27 15.24
(7.33, 31.69)
0.0; 0.34

Abbreviations: Het = Heterogeneity; PLR = positive likelihood ratio; NLR = negative likelihood ratio; DOR = diagnostic odds ratio; I2 = I-square; CI = confidence interval; P = P value.

Fig 5. HSROC curve of PCR tests used to diagnose S. japonicum infections.

Fig 5

Subgroup analyses did not reveal the possible sources of heterogeneity as I square of all pooled indexes within a majority of subgroups were more than 50% with P values <0.01. Table 3 displays the pooled estimates for each subgroup. In terms of research design, the significantly higher estimates in diagnostic accuracy were obtained for case-control studies than cross-sectional studies (Chi square = 15.72, P<0.01). No significant difference was seen between stool-based and blood-based PCR (Chi square = 0.08, P = 0.78). There was significant differences among the four types of PCR techniques (Chi square = 11.90, P<0.01) with the highest estimates of accuracy obtained for nested PCR. Their HSROC curves (with 95% CIs and 95% prediction regions) are shown in Fig 6. Because there was only two studies of droplet digital PCR, the corresponding HSROC curve cannot be drawn. The multivariate regression analyses, with research design, biological samples and PCR types as covariates, showed that research design may influence the diagnostic accuracy.

Fig 6.

Fig 6

HSROC curves of subgroup analyses based on research design (A and B), biological samples (C and D) and PCR method (E-G). A) case-control design, B) cross-sectional design, C) based on blood samples, D) based on stool samples, E) conventional PCR, F) nested PCR, G) real-time PCR.

Discussion

In this meta-analysis, we analyzed and summarized the data from relevant studies of variable-temperature PCR used for the diagnosis of S. japonicum infections in humans in endemic areas, based on DNA extracted from stool or blood samples. A total of 13 articles, 16 sets of data and 4268 participants were included. There was high heterogeneity among studies, but no publication bias was found. The bivariate mixed-effect model revealed that these PCR techniques had a satisfactory performance in diagnosis for S. japonicum infections with both high sensitivity and specificity.

The high heterogeneity between these included studies might be due to several reasons. First, this research included two distinct types of research design, case-control and cross-sectional designs. Second, sample size of included studies varied greatly, ranging from 23 to 1371 participants. Finally, studies involved four different types of PCR approaches, seven different target genes and DNA extracted from stool or blood [33,4960]. Considering both intra- and inter-study variability, the bivariate mixed-effect model was applied in estimating the diagnostic performance of the overall studies and it’s subgroups.

Sensitivity and specificity are true performance statistics of an index test. The results from our study showed the overall diagnostic performance of PCR had an average high sensitivity of 91% and specificity of 85% with the diagnostic odds ratio of 58. This was considerably higher than the estimates reported in two previous meta-analyses [34,61], of which the former [34] included four studies only, and the latter [61] was based on various biological materials and from different host species including serum, feces, urine and saliva from humans, feces from pigs and tissues from snails. Our results suggests that these PCR techniques can be used as an effective tool for diagnosing S. japonicum infections in humans in both clinical practice and field surveys. The low pooled NLR of 0.10 suggested that a negative PCR result may provide enough evidence to rule out S. japonicum infection. However, it is noted that the pooled PLR was only 5.90, less than 10 recommended [46,47], suggesting that individuals with PCR-positive results should be further confirmed by using other diagnostic assays or repeat tests. One reason for this could also come from the period of four to fourteen weeks required for parasite DNA to disintegrate and disappear in hosts after treatment [62]. Further analyses of diagnostic sensitivities pre and post treatment could help to elucidate this. Furthermore this low PLR should be interpreted with caution as it is worth noting that diagnostic performance of the PCR methods in these publications, and therefore in this meta-analysis, might be underestimated due to the use of Kato-Katz as the reference standard. As Kato-Katz are known to have low sensitivity, particularly in hosts with low infection intensities, positive results by PCR for those who are Kato-Katz negative may be likely to be true positives, rather than false positives. As schistosome worms can not be directly counted, all diagnostics, whether detecting eggs, antigens, antibodies, or DNA are all acting as a proxy for worm burden. It is vital that diagnostic comparative studies moving forwards use latent class analyses given the lack of a true gold standard for Schistosoma infections [63,64].

Subgroup analysis was performed according to research design, biological samples and PCR types. For research design types, case-control studies reported better performances for PCR diagnostics than cross-sectional studies, as indicated by the estimates of pooled sensitivity, specificity, likelihood ratio and DOR. These better performances may partly come from a possible ‘overestimation’ of the diagnosis accuracy in case-control research, as previously proposed in [37,65]. In case-control studies, the participants are previously confirmed as either infected individuals (in the case group) or healthy and/or non-cases (in the control group); whereas in cross-sectional design studies, several participants truly infected with S. japonicum could be missed by Kato-Katz due to the low sensitivity of this reference assay [26]. Regarding biological sample type, it is generally assumed that, due to the irregular output of larval eggs in stool and the constant existence in serum of cell-free circulating DNA from schistosomes (paired or unpaired), the blood-based PCR should have better diagnostic performance than the stool-based [62]. However, we did not find any significant difference between the sample type, potentially due to the low number of studies being compared. Among the four sub groups of PCR approaches compared, the nested PCRs showed the highest diagnostic performance, indicating that further research focused on this technique may provide the optimal protocols. However, due to the overall low number of studies and comparisons, the other PCR methods should not be ruled out. Indeed qPCR and Droplet digital PCR may remain important if quantitative results are needed. Further multivariate analyses showed that the overall diagnostic performance was most affected by research design rather than by biological materials or PCR types, however as previously mentioned this may be due to the cohort selection rather than actual clinical or technical sensitivity and specificity of the specific tests.

Recently, we have proposed that single-sex schistosome infections in humans could be more common than dual-sex infections [66]. Following that, we provided evidence that single-sex schistosome infections remain capable of reproducing once their opposite-sex are available [67]. For these single sex infections, the conventional parasitological assays lose function because no eggs are produced or excreted and therefore there will be no eggs in hosts’ stools [68]. PCR techniques, on the other hand, detect schistosome DNA, making it possible to detect such unisexual infections [51]. Further research on the development of PCR techniques to detect single sex S. japonicum infections is warranted as we currently do not know the prevalence of such infections in humans or other definitive hosts and therefore cannot elucidate the larger implications of these as we move towards elimination of S. japonicum.

There are some limitations in this meta-analysis. First, out of the sixteen studies included, seven were case-control studies, in which most did not apply a blinding method which resulted in a high risk of “Patient Selection” and “Index Test”. This might have overestimated the diagnostic accuracy of PCR. Second, it is impossible to analyze the influence of different target genes on diagnostic accuracy due to the small number of studies included targeting each. Thirdly, the heterogeneity was not explained fully by subgroup analyses. Fourthly, the effect of infection intensity of diagnostic accuracy could not be assessed through this meta analysis, despite it’s known effect. Finally, as most published studies use Kato-Katz as the reference standard for S. japonicum this was part of our inclusion criteria. However, the majority of studies did not use latent class analysis to estimate the sensitivities and specificities of the different PCR tests, which may have resulted in under-estimates of specificity. However, despite this all four PCR methods were found to disply high sensitivities and specificities and therefore are interpreted to be adequate for use for monitoring and evaluation in S. japonicum endemic areas as we move towards elimination.

Conclusions

This meta-analysis showed that variable-temperature PCR had a satisfactory performance in diagnoses for S. japonicum infections. More exploration on diagnostic techniques, especially in low endemic areas for detection of S. japonicum dual-sex and possible single-sex infections, using high-quality studies, highly sensitive gene targets and ideally nested PCRs, is required, to help support S. japonicum endemic areas progress towards the WHO 2030 target, and to monitor if and when it is achieved.

Supporting information

S1 Table. PRISMA checklist.

(DOCX)

S1 Fig

Risk of bias and applicability concerns summary (A) and graph (B).

(TIF)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The authors M-TS, M-MG, J-YZ, Q-FY and D-BL and/or their research are currently funded by the National Science Foundation of China (to DL, No. 81971957). PHLL is funded by a European Research Council Starting Grant (680088 SCHISTO_PERSIST), the Wellcome Trust (grant number 204820/Z/16/Z) the Engineering and Physical Sciences Research Council (EP/T003618/1 and EP/R01437X/1), and the Medical Research Council (MR/P025447/1). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.

References

  • 1.Ullah H, Arbab S, Khan MIU, Li K, Muhammad N, Suleman, et al. Circulating cell-free mitochondrial DNA fragment: A possible marker for early detection of Schistosoma japonicum. Infection, Genetics and Evolution 2021;88:104683. Epub 2020/12/22. doi: 10.1016/j.meegid.2020.104683 . [DOI] [PubMed] [Google Scholar]
  • 2.Lo NC, Addiss DG, Hotez PJ, King CH, Stothard JR, Evans DS, et al. A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now. The Lancet Infectious Diseases. 2017;17(2):e64–e9. doi: 10.1016/S1473-3099(16)30535-7 ; PubMed Central PMCID: PMC5280090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.King CH. It’s time to dispel the myth of "asymptomatic" schistosomiasis. PLoS Neglected Tropical Diseases. 2015;9(2):e0003504. Epub 2015/02/20. doi: 10.1371/journal.pntd.0003504 ; PubMed Central PMCID: PMC4335065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. The Lancet. 2014;383(9936):2253–64. doi: 10.1016/s0140-6736(13)61949-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ross AG, Chau TN, Inobaya MT, Olveda RM, Li Y, Harn DA. A new global strategy for the elimination of schistosomiasis. International Journal of Infectious Diseases. 2017;54:130–7. Epub 2016/12/13. doi: 10.1016/j.ijid.2016.09.023 . [DOI] [PubMed] [Google Scholar]
  • 6.Chen MG. Assessment of morbidity due to Schistosoma japonicum infection in China. Infectious Diseases of poverty. 2014;3(6). doi: 10.1186/2049-9957-3-6 ; PubMed Central PMCID: PMC3928580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang L, Utzinger J, Zhou XN. Schistosomiasis control: experiences and lessons from China. The Lancet. 2008;372(9652):1793–5. doi: 10.1016/S0140-6736(08)61358-6 ; PubMed Central PMCID: PMC7135384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zou HY, Yu QF, Qiu C, Webster JP, Lu DB. Meta-analyses of Schistosoma japonicum infections in wild rodents across China over time indicates a potential challenge to the 2030 elimination targets. PLoS Neglected Tropical Diseases. 2020;14(9):e0008652. doi: 10.1371/journal.pntd.0008652 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Qiu C, Zou HY, Deng Y, Liang YS, Lu DB. A meta-analysis of infection rates of Schistosoma japonicum in sentinel mice associated with infectious waters in mainland China over last 40 years. PLoS Neglected Tropical Diseases. 2019;13(6):e0007475. doi: 10.1371/journal.pntd.0007475 ; PubMed Central PMCID: PMC6584001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zhang LJ, Xu ZM, Dang H, L YL, Lv S, Xu J, et al. Endemic status of schistosomiasis in People’s Republic of China in 2019. Chinese Journal of Schistosomiasis Control. 2020;32(6):551–8. Epub 2020/12/17. doi: 10.16250/j.32.1374.2020263 . [DOI] [PubMed] [Google Scholar]
  • 11.Lei ZL, Zhou XN. Eradication of schistosomiasis: a new target and a new task for the National Schistosomiasis Control Porgramme in the People’s Republic of China. Chinese Journal of Schistosomiasis Control. 2015;27(1). doi: 10.16250/j.32.1374.2015036 [DOI] [PubMed] [Google Scholar]
  • 12.Zhou XN. Implementation of precision control to achieve the goal of schistosomiasis elimination in China. Chinese Journal of Schistosomiasis Control. 2016;28(1). doi: 10.16250/j.32.1374.2016001 [DOI] [PubMed] [Google Scholar]
  • 13.TANAKA H, TSUJI M. From discovery to eradication of Schistosomiasis in Japan 1847–1996. International Journal for Parasitology. 1997;27(12):1465–80. doi: 10.1016/s0020-7519(97)00183-5 . [DOI] [PubMed] [Google Scholar]
  • 14.Olveda DU, Li Y, Olveda RM, Lam AK, McManus DP, Chau TN, et al. Bilharzia in the Philippines: past, present, and future. International Journal of Infectious Diseases. 2014;18:52–6. Epub 2013/11/12. doi: 10.1016/j.ijid.2013.09.011 . [DOI] [PubMed] [Google Scholar]
  • 15.Gordon CA, Kurscheid J, Williams GM, Clements ACA, Li Y, Zhou XN, et al. Asian Schistosomiasis: Current status and prospects for control leading to elimination. Tropical Medicine and Infectious Disease. 2019;4(1). Epub 2019/03/01. doi: 10.3390/tropicalmed4010040 ; PubMed Central PMCID: PMC6473711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Khieu V, Sayasone S, Muth S, Kirinoki M, Laymanivong S, Ohmae H, et al. Elimination of Schistosomiasis mekongi from endemic areas in Cambodia and the Lao People’s Democratic Republic: Current status and plans. Tropical Medicine and Infectious Disease. 2019;4(1). Epub 2019/02/10. doi: 10.3390/tropicalmed4010030 ; PubMed Central PMCID: PMC6473609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.WHO. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. 2020. Available from: https://www.who.int/publications/i/item/9789240010352 [Google Scholar]
  • 18.WHO. Diagnosetic target product profiles for monitoring, evaluation and surveillance of schistosomiasis control programmes. 2021. Available from: https://www.who.int/publications/i/item/9789240031104 [Google Scholar]
  • 19.Utzinger J, Becker SL, van Lieshout L, van Dam GJ, Knopp S. New diagnostic tools in schistosomiasis. Clinical Microbiology and Infection. 2015;21(6):529–42. doi: 10.1016/j.cmi.2015.03.014 . [DOI] [PubMed] [Google Scholar]
  • 20.WHO. Schistosomiasis: progress report 2001–2011 and stratetegic plan 2012–2020. 2013. Available from: https://www.who.int/publications/i/item/978941503174. [Google Scholar]
  • 21.Tarafder MR, Carabin H, Joseph L, Balolong E Jr., Olveda R, McGarvey ST. Estimating the sensitivity and specificity of Kato-Katz stool examination technique for detection of hookworms, Ascaris lumbricoides and Trichuris trichiura infections in humans in the absence of a ’gold standard’. International Journal for Parasitology. 2010;40(4):399–404. Epub 2009/09/24. doi: 10.1016/j.ijpara.2009.09.003 ; PubMed Central PMCID: PMC2829363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hinz R, Schwarz NG, Hahn A, Frickmann H. Serological approaches for the diagnosis of schistosomiasis—A review. Molecular and Cellular Probes. 2017;31:2–21. Epub 2016/12/18. doi: 10.1016/j.mcp.2016.12.003 . [DOI] [PubMed] [Google Scholar]
  • 23.Agbata EN, Morton RL, Bisoffi Z, Bottieau E, Greenaway C, Biggs BA, et al. Effectiveness of screening and treatment approaches for schistosomiasis and strongyloidiasis in newly-arrived migrants from endemic countries in the EU/EEA: A systematic review. International Journal of Environmental Research and Public Health. 2018;16(1):1–41. Epub 2018/12/24. doi: 10.3390/ijerph16010011 ; PubMed Central PMCID: PMC6339107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Antje F, Deogratias MH, Tappe D, Kasang C, Mueller A. Comparison of sensitivity and specificity of three diagnostic tests to detect Schistosoma mansoni infections in school children in Mwanza region, Tanzania. PLoS One. 2018;13(8):1–14. doi: 10.1371/journal.pone.0202499 ; PubMed Central PMCID: PMC6105001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ogongo P, Kariuki TM, Wilson RA. Diagnosis of schistosomiasis mansoni: an evaluation of existing methods and research towards single worm pair detection. Parasitology. 2018;145(11):1355–66. Epub 2018/03/07. doi: 10.1017/S0031182018000240 . [DOI] [PubMed] [Google Scholar]
  • 26.Mesa LE, Manrique R, Muskus C, Robledo SM. Test accuracy of polymerase chain reaction methods against conventional diagnostic techniques for Cutaneous Leishmaniasis (CL) in patients with clinical or epidemiological suspicion of CL: Systematic review and meta-analysis. PLoS Neglected Tropical Diseases. 2020;14(1):e0007981. Epub 2020/01/22. doi: 10.1371/journal.pntd.0007981 ; PubMed Central PMCID: PMC6994169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chang LJ, Hsiao CJ, Chen B, Liu TY, Ding J, Hsu WT, et al. Accuracy and comparison of two rapid multiplex PCR tests for gastroenteritis pathogens: a systematic review and meta-analysis. BMJ Open Gastroenterol. 2021;8(1). Epub 2021/03/03. doi: 10.1136/bmjgast-2020-000553 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cai P, Weerakoon KG, Mu Y, Olveda RM, Ross AG, Olveda DU, et al. Comparison of Kato Katz, antibody-based ELISA and droplet digital PCR diagnosis of schistosomiasis japonica: Lessons learnt from a setting of low infection intensity. PLoS Neglected Tropical Diseases. 2019;13(3):e0007228. Epub 2019/03/05. doi: 10.1371/journal.pntd.0007228 ; PubMed Central PMCID: PMC6417743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Green MR, Sambrook J. Nested Polymerase Chain Reaction (PCR). Cold Spring Harb Protoc. 2019;2019(2). Epub 2019/02/03. doi: 10.1101/pdb.prot095182 . [DOI] [PubMed] [Google Scholar]
  • 30.Larsen HH, Masur H, Kovacs JA, Gill VJ, Silcott VA, Kogulan P, et al. Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. Journal of Clinical Microbiology. 2002;40(2):490–4. Epub 2002/02/05. doi: 10.1128/JCM.40.2.490-494.2002 ; PubMed Central PMCID: PMC153364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ren J, Deng T, Huang W, Chen Y, Ge Y. A digital PCR method for identifying and quantifying adulteration of meat species in raw and processed food. PLoS One. 2017;12(3):e0173567. Epub 2017/03/21. doi: 10.1371/journal.pone.0173567 ; PubMed Central PMCID: PMC5358868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Deprez L, Corbisier P, Kortekaas AM, Mazoua S, Beaz Hidalgo R, Trapmann S, et al. Validation of a digital PCR method for quantification of DNA copy number concentrations by using a certified reference material. Biomol Detect Quantif. 2016;9:29–39. Epub 2016/09/13. doi: 10.1016/j.bdq.2016.08.002 ; PubMed Central PMCID: PMC5007884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Weerakoon KG, Gordon CA, Williams GM, Cai P, Gobert GN, Olveda RM, et al. Droplet digital PCR diagnosis of human schistosomiasis: Parasite cell-free DNA detection in diverse clinical samples. Journal of Infectious Diseases. 2017;216(12):1611–22. Epub 2017/10/14. doi: 10.1093/infdis/jix521 . [DOI] [PubMed] [Google Scholar]
  • 34.Rahman MO, Sassa M, Parvin N, Islam MR, Yajima A, Ota E. Diagnostic test accuracy for detecting Schistosoma japonicum and S. mekongi in humans: A systematic review and meta-analysis. PLoS Neglected Tropical Diseases. 2021;15(3):e0009244. Epub 2021/03/18. doi: 10.1371/journal.pntd.0009244 ; PubMed Central PMCID: PMC7968889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. Epub 2021/03/31. doi: 10.1136/bmj.n71 ; PubMed Central PMCID: PMC8005924 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Leeflang MMG, Deeks JJ, Gatsonis C, Bossuyt PMM. Systematic Reviews of Diagnostic Test Accuracy. Annals of Internal Medicine. 2008;149(12):889–97. doi: 10.7326/0003-4819-149-12-200812160-00008 ; PubMed Central PMCID: PMC2956514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Johannes B. Reitsma M, et al. QUADAS-2 A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies. Annals of Internal Medicine. 2018;155(8):529–36. doi: 10.7326/0003-4819-155-8-201110180-00009 . [DOI] [PubMed] [Google Scholar]
  • 38.Zeng XT, Li S, Lei J, Y G. Application of Review Manager 5 Software for Meta-analysis of Diagnostic Test Accuracy. Journal of Hubei University of Medicine. 2013;32(1):6–16. CNKI:SUN:YYYX.0.2013-01-001. [Google Scholar]
  • 39.Zhang TS, Xiong Q. HSROC Model in Meta·Analysis of Diagnostic Test and Its Solution in Stata. The Journal of Evidenced-Based Medicine. 2012;12(4):241–3. doi: 10.3969/j.issn.1671-5144.2012.04.016 [DOI] [Google Scholar]
  • 40.Zhou JG, Tian X, Tian JH, Zhou Q, Ma H. Application of HSROC package of R software in combination with review manager 5.3 for Meta analysis of diagnostic test accuraty. Journal of Zunyi Medical University. 2015;38(3):308–12. doi: 10.14169/j.cnki.zunyixuebao.2015.0074 [DOI] [Google Scholar]
  • 41.Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Australian and New Zealand Journal of Psychiatry. 2003;327(7414):557–60. doi: 10.1136/bmj.327.7414.557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Devillé WL, Buntinx F, Bouter LM, MMontori V, Vet HCd, Windt DAvd, et al. Conducting systematic reviews of diagnostic studies didactic guidelines. Medical Research Methodology. 2002. doi: 10.1186/1471-2288-2-9 PubMed Central PMCID: PMC117243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology. 2005;58(9):882–93. Epub 2005/08/09. doi: 10.1016/j.jclinepi.2005.01.016 . [DOI] [PubMed] [Google Scholar]
  • 44.Goldberg KM, Iglewicz B. Bivariate Extensions of the Boxplot. Technometrics. 1992;34(3):307–20. doi: 10.1080/00401706.1992.10485280 [DOI] [Google Scholar]
  • 45.Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology. 2005;58(10):982–90. Epub 2005/09/20. doi: 10.1016/j.jclinepi.2005.02.022 . [DOI] [PubMed] [Google Scholar]
  • 46.Lu Y, Chen YQ, Guo YL, Qin SM, Wu C, Wang K. Diagnosis of invasive fungal disease using serum (1→3)-beta-D-glucan: a bivariate meta-analysis. Internal Medicine. 2011;50(22):2783–91. Epub 2011/11/16. doi: 10.2169/internalmedicine.50.6175 . [DOI] [PubMed] [Google Scholar]
  • 47.Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. The Lancet Infectious diseases. 2009;9(2):89–96. doi: 10.1016/S1473-3099(09)70019-2 . [DOI] [PubMed] [Google Scholar]
  • 48.Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Statistics in Medicine. 2001;20(19):2865–84. Epub 2001/09/25. doi: 10.1002/sim.942 . [DOI] [PubMed] [Google Scholar]
  • 49.Fung MS, Xiao N, Wang S, Carlton EJ. Field evaluation of a PCR test for Schistosoma japonicum egg detection in low-prevalence regions of China. American Society of Tropical Medicine and Hygiene. 2012;87(6):1053–8. Epub 2012/10/31. doi: 10.4269/ajtmh.2012.12-0177 ; PubMed Central PMCID: PMC3516074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Gordon CA, Acosta LP, Gobert GN, Olveda RM, Ross AG, Williams GM, et al. Real-time PCR demonstrates high prevalence of Schistosoma japonicum in the Philippines: implications for surveillance and control. PLoS Neglected Tropical Diseases. 2015;9(1):e0003483. Epub 2015/01/22. doi: 10.1371/journal.pntd.0003483 ; PubMed Central PMCID: PMC4301913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Wei G. Real-time PCR for dynamic changes of the serum DNA in hosts infected with S. japonicum and diagnosis and therapy evaluation of schistosomiasis [Master Thesis]: Soochow University; 2013.
  • 52.Guo JJ, Zheng HJ, Xu J, Zhu XQ, Wang SY, Xia CM. Sensitive and specific target sequences selected from retrotransposons of Schistosoma japonicum for the diagnosis of schistosomiasis. PLoS Neglected Tropical Diseases. 2012;6(3):e1579. Epub 2012/04/06. doi: 10.1371/journal.pntd.0001579 ; PubMed Central PMCID: PMC3313927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kato-Hayashi N, Leonardo LR, Arevalo NL, Tagum MN, Apin J, Agsolid LM, et al. Detection of active schistosome infection by cell-free circulating DNA of Schistosoma japonicum in highly endemic areas in Sorsogon Province, the Philippines. Acta Tropical. 2015;141(Pt B):178–83. doi: 10.1016/j.actatropica.2014.05.003 . [DOI] [PubMed] [Google Scholar]
  • 54.Lier T, Simonsen GS, Wang T, Lu D, Haukland HH, Vennervald BJ, et al. Real-Time Polymerase Chain Reaction for Detection of Low-Intensity Schistosoma japonicum Infections in China. American Journal of Tropical Medicine and Hygiene. 2009;81(3):428–32. doi: 10.1016/j.actatropica.2009.05.010 . [DOI] [PubMed] [Google Scholar]
  • 55.Mu Y, Cai P, Olveda RM, Ross AG, Olveda DU, McManus DP. Parasite-derived circulating microRNAs as biomarkers for the detection of human Schistosoma japonicum infection. Parasitology. 2020;147(8):889–96. Epub 2019/12/17. doi: 10.1017/S0031182019001690 ; PubMed Central PMCID: PMC7391863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Wang ZL, Wang TP, Wang QZ, Yin XM, Zhou L, Wang FF, et al. Application value of fecal PCR assay in the diagnosis of schistosomiasis japonica. Journal of Tropical Disease and Parasitology. 2009;7(1):10–2. doi: 10.3969/j.issn.1672-2302.2009.01.004 [DOI] [Google Scholar]
  • 57.Xu J, Rong R, Zhang HQ, Shi CJ, Zhu XQ, Xia CM. Sensitive and rapid detection of Schistosoma japonicum DNA by loop-mediated isothermal amplification (LAMP). International Journal of Parasitology. 2010;40(3):327–31. Epub 2009/09/09. doi: 10.1016/j.ijpara.2009.08.010 . [DOI] [PubMed] [Google Scholar]
  • 58.Xu J. Loop-mediated isothermal Amplification (LAMP) for early diagnosis and therapy evaluation of Schistosoma japonicum infection [Doctor Thesis]: Soochow University; 2011.
  • 59.Xu XD, Zhang YB, Lin DD, Zhang JJ, Xu J, Liu YM, et al. Serodiagnosis of Schistosoma japonicum infection: genome-wide identification of a protein marker, and assessment of its diagnostic validity in a field study in China. The Lancet Infectious Diseases. 2014;14(6):489–97. doi: 10.1016/S1473-3099(14)70067-2 . [DOI] [PubMed] [Google Scholar]
  • 60.Zeng FS, He L, He XM, Yang J, Qin ZQ. Nested-PCR assay for detection of Schistosoma japonicum. Journal of Tropical Disease and Parasitology. 2017;15(3):136–8. doi: 10.3969/j.issn.1672-2302.2017.03.003 [DOI] [Google Scholar]
  • 61.Wang SL, Wang LP, Wu LL, Li YL, Zhang LJ, Lu S, et al. Diagnostic value of nucleic acid detection in schistosomiasis japonica: a meta⁃analysis. Chinese Journal of Schistosomiasis Control. 2020;32(1):15–22. Epub 2020/03/19. doi: 10.16250/j.32.1374.2019174 . [DOI] [PubMed] [Google Scholar]
  • 62.Xu J, Liu AP, Guo JJ, Wang B, Qiu SJ, Sun H, et al. The sources and metabolic dynamics of Schistosoma japonicum DNA in serum of the host. Parasitol Res. 2013;112(1):129–33. doi: 10.1007/s00436-012-3115-3 . [DOI] [PubMed] [Google Scholar]
  • 63.Prada JM, Touloupou P, Adriko M, Tukahebwa EM, Lamberton PHL, Hollingsworth TD. Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda. Parasit Vectors. 2018;11(1):21. Epub 2018/01/10. doi: 10.1186/s13071-017-2580-z ; PubMed Central PMCID: PMC5759883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Clark J, Arinaitwe M, Nankasi A, Faust CL, Moses A, Ajambo D, et al. Reconciling egg- and antigen-based estimates of Schistosoma mansoni clearance and reinfection: a modelling study. Clin Infect Dis. 2021. Epub 2021/08/07. doi: 10.1093/cid/ciab679 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, Meulen JHPvd, et al. Empirical Evidence of Design-Related Bias in Studies of Diagnostic Tests. JAMA. 1999;282(11):1061–6. doi: 10.1001/jama.282.11.1061 . [DOI] [PubMed] [Google Scholar]
  • 66.Lu DB, Deng Y, Ding H, Liang YS, Webster JP. Single-sex schistosome infections of definitive hosts: Implications for epidemiology and disease control in a changing world. PLoS Pathogens. 2018;14(3):e1006817. doi: 10.1371/journal.ppat.1006817 ; PubMed Central PMCID: PMC5833269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Lu DB, Yu QF, Zhang JY, Sun MT, Gu MM, Webster JP, et al. Extended survival and reproductive potential of single-sex male and female Schistosoma japonicum within definitive hosts. Int J Parasitol. 2021. Epub 2021/04/28. doi: 10.1016/j.ijpara.2021.03.005 . [DOI] [PubMed] [Google Scholar]
  • 68.Jing Xu, Chen NG, Feng T, Wang EM, Wu XH, Chen HG, et al. Effectiveness of Routinely Used Assays for the Diagnosis of Schistosomiasis japonica in the Field. Chinese Journal of Parasitology and Parasitic Diseases 2007;25(3):175–9. doi: 10.3969/j.issn.1000-7423.2007.03.004 [DOI] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010136.r001

Decision Letter 0

John Stuart Gilleard, Elizabeth J Carlton

17 Oct 2021

Dear Dr Lu ,

Thank you very much for submitting your manuscript "Meta-analysis of variable-temperature PCR technique performance for Schistosoma japonicum infections in humans" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

In addition to the referees comments below, there is a need to proof read the manuscript for English grammar as there are quite a lot of grammatical errors throughout . As one example to give you an idea of what is required : eg lines 110-111 it states "However, it has been proved to be low sensitive in people...." Grammatically this should be "However, it has been proven to be of low sensitivity in people....."

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

John Stuart Gilleard

Associate Editor

PLOS Neglected Tropical Diseases

Elizabeth Carlton

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

In addition to the referees comments below, there is a need to proof read the manuscript for English grammar as there are quite a lot of grammatical errors throughout . As one example to give you an idea of what is required : eg lines 110-111 it states "However, it has been proved to be low sensitive in people...." Grammatically this should be "However, it has been proven to be of low sensitivity in people....."

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: Accepted. The authors have also searched Chinese databases looking for studies to include, and that is an advantage. The selection criteria and selection process is properly described, and so is the statistical methods used.

Reviewer #2: Yes

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Accepted. Two minor suggestions; the phrases ‘traditional PCR’ and ‘conventional PCR’ are both used in the text and figures in the meaning of non-realtime PCR. The same phrase should be used throughout, preferably ‘conventional PCR’. In Table 1 the abbreviations Tp, Fp, Fn and Tn must be explained somewhere, i.e. written out in full.

Reviewer #2: The quality of the figures (Fig 1 and 2) are not clearly visible. It need some modification.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Accepted. Studies that look at diagnostic methods for Schistosoma infections has a challenge in that there is a lack of a good reference method with high sensitivity and specificity to which you can compare a ‘new’ test. When you compare a ‘new’ test (such as PCR), which might be a more accurate test, with a ‘poor’ reference method (with low sensitivity or specificity) the perceived performance of the ‘new’ test would be worse than the ‘true’ performance. Whether you for instance choose microscopy or antibodies as reference method might have a huge impact. Suggest a short mentioning/discussion of this.

The phrase ‘The common serological methods, e.g., based on the soluble antigen of eggs have also been proven to be useless.’ This might be a bit too categorical statement that is not fully supported by the reference. Suggest a slight moderation.

The authors suggest using blood-based PCR in stead of stool, mainly for practical reasons/higher compliance. This is true, but some blood-based Schistosoma PCR methods has been shown to be positive for a long time after treatment. Would that be of any consequence?

Reviewer #2: Yes

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: The term 'highly sensitive genes' is being used. Suggest using 'highly sensitive PCR targets' or 'gene targets' as genes themselves are not 'sensitive'.

Suggest rephrasing a few sentences I find complicated or unclear:

Line 309; we have proposed that single-sex schistosome infections in humans should be more common.. Use 'could'?

Line 316: Further research on the development of the detection is wanted as we would know what prevalence of such infections in humans or other hosts could be, if such methods are available. Complicated/unclear. Rephrase?

Reviewer #2: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This study is of interest because the epidemiological situation in many of the S japonicum-endemic areas, with low prevalence and low intensity infections, makes it necessary to look into new and improved diagnostics. The results are not novel per se, but the authors do a good job by collecting and analysing the different studies, including from Chinese databases. One challenge with this meta-analysis, also commented by the authors, is the heterogenicity of the included studies in terms of study design, PCR targets/methods etc. This makes it more difficult to draw conclusions.

A reader who is interested in diagnostics for S japonicum might not be familiar with the statistical methods for meta-analysis used in this study. That you might argue is a problem for the reader, not the authors.

Reviewer #2: Reviewer report

The manuscript addresses the evaluation of molecular diagnostic technique in titled “Meta-analysis of variable -temperature PCR technique performance for Schistosoma japonicum infections in human”. Performance evaluation of sensitive diagnostic techniques such as PCR is very relevant in the area where there is a low prevalence of S. japonicum infection which is unable to detect even using the gold standard Kato-Katz techniques. The manuscript is original, relevant and well organized to be publishable with slight modifications.

Minor comments

The title is not geographically delimited but in the result section lines, 210 & 211 indicated that all studies were conducted in schistosomiasis endemic areas of China or the Philippines. If all the data included in the analysis were from these two countries, it may need some modification of the title.

Abstract:

Results: the title is about PCR technique performance. Which PCR approach performed best and which one is poorly performed? I suggest a subgroup analysis by PCR approaches.

Conclusion: if you conduct subgroup analysis by PCR methods, your conclusions may also be modified.

Keywords: the keyword shall be arranged alphabetically.

Introduction: It will be nice if you included some introductory information about some of the PCR approaches being used for the detection of S. japonicum.

Results:

Line 2-12-213: It is indicated that different PCR techniques were used among the 13 studies included in the meta-analysis. It will be nice if you compare the results of the different PCR approaches (traditional, two droplets digital, real-time and nested PCR). Which PCR approaches have better sensitivity, specificity, PLR, NLR and DOR? In other words, you may conduct a subgroup analysis by PCR methods. This information helps you to forward better recommendation in the types of diagnostic method shall be used in low prevalence areas.

Table 1: You have to add a key at the bottom of the table indicating Tp, Ep, Fn and Tn.

Fig 1and 2 are not visible for the readers. It needs some modifications.

Conclusion: If you perform subgroup analysis by types of PCR techniques, your conclusion might be modified. As you recommended blood-based PCR is better than stool-based PCR approaches.

List of abbreviations: several abbreviations are available in the manuscript but lack the list of abbreviations. It will be nice if you include the list of abbreviations.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tore Lier

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

Attachment

Submitted filename: Reviewer report.docx

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010136.r003

Decision Letter 1

John Stuart Gilleard, Elizabeth J Carlton

3 Jan 2022

Dear Dr Lu,

We are pleased to inform you that your manuscript 'Meta-analysis of variable-temperature PCR technique performance for diagnosing Schistosoma japonicum infections in humans in endemic areas' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

John Stuart Gilleard

Associate Editor

PLOS Neglected Tropical Diseases

Elizabeth Carlton

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010136.r004

Acceptance letter

John Stuart Gilleard, Elizabeth J Carlton

12 Jan 2022

Dear Dr. Lu,

We are delighted to inform you that your manuscript, "Meta-analysis of variable-temperature PCR technique performance for diagnosising Schistosoma japonicum infections in humans in endemic areas," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. PRISMA checklist.

    (DOCX)

    S1 Fig

    Risk of bias and applicability concerns summary (A) and graph (B).

    (TIF)

    Attachment

    Submitted filename: Reviewer report.docx

    Attachment

    Submitted filename: Responses to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES